Short-period-induced hypertension could improve tumor-to-nontumor ratios of radiolabeled monoclonal antibody

Nuclear Medicine and Biology

Volumn 24, Issue 6, 1997, Pages 547-551

  Kinuya, Seigo ^a   Yokoyama, Kunihiko ^a   Yamamoto, Wakako ^b   Konishi, Shota ^a   Shuke, Noriyuki ^b   Aburano, Tamio ^b   Watanabe, Naoto ^c   Takayama, Teruhiko ^d   Michigishi, Takatoshi ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Induced hypertension; Monoclonal antibody; Tumor targeting

Indexed keywords

ANGIOTENSIN; HUMAN SERUM ALBUMIN TC 99M; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY A7 IN 111; MONOCLONAL ANTIBODY IN 111; PENTETATE INDIUM IN 111; THALLIUM CHLORIDE TL 201; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; RADIOISOTOPE DISTRIBUTION; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANGIOTENSIN II; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HYPERTENSION; INDIUM RADIOISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; RADIOIMMUNODETECTION; TISSUE DISTRIBUTION;

EID: 0030767236     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00076-0     Document Type: Article

References (19)

1. Abe I., Hori K., Saito S., Tanda S., Li Y. and Suzuki M. (1988) Increased intratumor concentration of fluorescein-isothiocyanato-labeled neocarzinostatin in rats under angiotensin-induced hypertension. Jpn. J. Cancer Res. (Gann) 79, 874-879.
2. Caulser C., Macapinlac H., Healey J., Ghavimi F., Meyers P., Wollner N. et al. (1992) The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin. Nucl. Med. 17, 565-572.
3. Hori K., Suzuki M., Abe I., Saito S. and Sato H. (1985) Increase in tumor vascular area due to increased blood flow by angiotensin II. J. Natl. Cancer Inst. 74, 453-459.
4. 111In-labeled monoclonal antibody. Nucl. Med. Biol. 23, 137-140.
5. 99mTc-human serum albumin for assessment of the effect of hypertensive treatment with angiotensin II infusion on tumour circulation. Nucl. Med. Commun. 17, 160-163.
6. LeBerthon B., Khawli L. A., Alauddin M., Miller G. K., Charak B. S., Mazumdar A. et al. (1991) Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate. Cancer Res. 51, 2694-2698.
7. Li J., Merton D. A., Thakur M. L., Barr J., Wilder S., O'Hara M. D. et al. (1994) Influence of biological response modifiers: Measurement of tumor blood flow and temperature. J. Immunother. 16, 175-180.
8. m-labelled monoclonal antibodies. Nucl. Med. Commun. 17, 346-352.
9. Li J., Merton D. A., Duggaraju R. and Thakur M. L. (1996) Augmenting of tumor uptake of anti-melanoma antibody MEM136: Influence of interferon. Nucl. Med. Biol. 23, 873-879.
10. Khawli L. A., Miller G. K. and Epstein A. L. (1994) Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer (Suppl) 73, 824-831.
11. Matsumura Y., Kimura M., Yamamoto T. and Maeda H. (1988) Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn. J. Cancer Res. (Gann) 79, 1327-1334.
12. Noguchi A., Takahashi T., Yamaguchi T., Kitamura K., Noguchi A., Tsurumi H. et al. (1992) Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II. Jpn. J. Cancer Res. (Gann) 83, 240-243.
13. Ong G. L. and Mattes M. J. (1989) Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res. 49, 4264-4273.
14. Paik C. H., Ebbert M. A., Murphy P. R., Lassman C. R., Reba R. C., Eckelman W. C. et al (1983) Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. J. Nucl. Med. 24, 1158-1163.
15. Sands H., Jones P. L., Shah S. A., Palme D., Vessella R. L. and Gallagher B. M. (1988) Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human renal cell xenografts. Cancer Res. 48, 188-193.
16. Sehweil A., el-Sayed M., Ziada G., Al-huda F., Mobarak L., Omar Y. T. et al. (1986) Thallium-201 kinetics in malignant tumors. J. Nucl. Med. 27, 1033.
17. Shulz K. R., Badger C. C., Dombi G. W., Greenberg P. D. and Bernstein I. D. (1992) Effect of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma. J. Natl. Cancer Inst. 84, 109-113.
18. Suzuki M., Hori K., Abe I., Saito S. and Sato H. (1981) A new approach of cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. J. Natl. Cancer Inst. 67, 663-669.
19. Taniguchi H., Koyama H., Masuyama M., Takeda A., Mugitani T., Tanaka H. et al. (1996) Angiotensin-II-induced hypertension chemotherapy: Evaluation of hepatic blood flow with oxygen-15 PET. J. Nucl. Med. 37, 1522-1523.